1. Introducing Cytology-Based Theranostics in Oral Squamous Cell Carcinoma: A Pilot Program.
- Author
-
Patrikidou A, Valeri RM, Kitikidou K, Destouni C, and Vahtsevanos K
- Subjects
- Aged, Aged, 80 and over, Biopsy, Carcinoma, Squamous Cell genetics, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Male, Middle Aged, Mouth Neoplasms genetics, Neoplasm Grading, Neoplasm Staging, Pilot Projects, Prognosis, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Survival Rate, Biomarkers, Tumor genetics, Carcinoma, Squamous Cell diagnosis, Cytodiagnosis methods, Gene Expression Profiling, Mouth Neoplasms diagnosis, Theranostic Nanomedicine
- Abstract
We aimed to evaluate the feasibility and reliability of brush cytology in the biomarker expression profiling of oral squamous cell carcinomas within the concept of theranostics, and to correlate this biomarker profile with patient measurable outcomes. Markers representative of prognostic gene expression changes in oral squamous cell carcinoma was selected. These markers were also selected to involve pathways for which commercially available or investigational agents exist for clinical application. A set of 7 markers were analysed by immunocytochemistry on the archival primary tumour material of 99 oral squamous cell carcinoma patients. We confirmed the feasibility of the technique for the expression profiling of oral squamous cell carcinomas. Furthermore, our results affirm the prognostic significance of the epidermal growth factor receptor (EGFR) family and the angiogenic pathway in oral squamous cell carcinoma, confirming their interest for targeted therapy. Brush cytology appears feasible and applicable for the expression profiling of oral squamous cell carcinoma within the concept of theranostics, according to sample availability.
- Published
- 2016
- Full Text
- View/download PDF